Skip to main content
Clinical Trials/NCT07823543
NCT07823543Not yet recruitingNot Applicable

Patient Education on Postoperative TSH Suppression Therapy for Differentiated Thyroid Cancer Using Science Popularization Videos: A Prospective, Multicenter, Randomized Controlled Trial

West China Hospital0 sites400 target enrollmentStarted: October 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
400
Primary Endpoint
TSH Compliance Rate

Study Overview

Brief Summary

The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients scheduled for thyroid surgery, aged between 18 and 60 years old

Exclusion Criteria

  • Unable to read and write, pregnant, or with a history of thyroid surgery;
  • suffering from other malignant tumors or mental disorders;
  • unable to complete the questionnaire independently or requiring assistance from others.

Arms & Interventions

Intervention group

Experimental

Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines

Intervention: Thyroid Surgery Educational Video (Other)

Non-intervention group

No Intervention

Without any additional intervention

Outcomes

Primary Outcomes

TSH Compliance Rate

Time Frame: Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12

The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are \< 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%

Patient satisfaction

Time Frame: Immediately after the educational presentation (post-intervention)

Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).

Secondary Outcomes

  • Level of knowledge dissemination(Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12)
  • Patient anxiety level(Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total)
  • Patient's Level of Regret After Surgery(Baseline (before the educational outreach) and immediately after the educational outreach)
  • Incidence of adverse events in patients(Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jianyong Lei

Professor

West China Hospital

Similar Trials